デフォルト表紙
市場調査レポート
商品コード
1595277

末梢血管デバイス市場:製品別、エンドユーザー別-2025年~2030年の世界予測

Peripheral Vascular Devices Market by Product (Angioplasty Balloons, Angioplasty Stents, Balloon Inflation Devices), End Users (Hospitals, Speciality Clinics) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 187 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.81円
末梢血管デバイス市場:製品別、エンドユーザー別-2025年~2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

末梢血管デバイス市場は、2023年に162億4,000万と評価され、2024年には182億3,000万米ドルに達すると予測され、CAGR 12.73%で成長し、2030年には375億8,000万米ドルになると予測されています。

末梢血管デバイス(PVDs)は、主に末梢循環系において、心臓や脳以外の血管関連疾患の診断や治療に使用される医療機器を包括しています。これらの医療機器は、血栓や手足の切断といった深刻な合併症を引き起こす可能性のある末梢血管疾患の管理に不可欠です。用途としては、血管形成術、ステント留置術、血栓除去術、アテレクトミーなどがあり、病院、専門クリニック、外来手術センターなどで使用されています。市場成長を後押しする要因としては、糖尿病や肥満などの生活習慣病有病率の上昇、世界人口の高齢化、低侵襲手技の技術進歩などが挙げられます。新興市場では、医療インフラの改善や医療費の増加により、PVDに対する需要が高まっています。主なビジネスチャンスは、再狭窄や異物反応といった現行技術の限界に対処する薬剤溶出デバイスや生体吸収性ステントの開発にあります。こうした機会を捉えるために、企業は革新的な研究開発と戦略的パートナーシップに投資すべきです。しかし、厳しい規制当局の承認、先進的なデバイスの高コスト、償還の問題などの課題は、市場拡大の妨げとなる可能性があります。代替療法との競合や熟練した医療従事者の必要性が、さらに複雑さを増しています。イノベーションは、医療機器の生体適合性の向上、手技リスクの軽減、個別化医療機器による患者の転帰の改善に焦点を当てるべきです。企業はまた、診断と治療を統合するハイブリッド技術を探求すべきです。PVD市場の性質はダイナミックで競争的であり、絶え間ない進歩と進化する規制基準に後押しされています。先を行くには、技術革新、患者層、ヘルスケア政策の変化を常に把握する必要があります。環境に優しい素材とコスト効率の高いソリューションを重視することで、新たな市場セグメントを開拓できる可能性があります。ビジネスの成長を促進するためには、積極的な患者教育キャンペーンに取り組み、新興市場で強固な販売網を構築することが重要な戦略です。

主な市場の統計
基準年[2023] 162億4,000万米ドル
予測年[2024] 182億3,000万米ドル
予測年[2030] 375億8,000万米ドル
CAGR(%) 12.73%

市場力学:急速に進化する末梢血管デバイス市場の主要市場インサイトを公開

末梢血管デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 肥満、糖尿病、高血圧に伴う末梢血管疾患の有病率の増加
    • 低侵襲治療に対する需要の高まり
    • 世界の老人人口の増加
  • 市場抑制要因
    • 装置の設置やメンテナンスに伴う高コスト
  • 市場機会
    • 末梢血管デバイスにおける技術進歩の高まり
    • 小児科患者の末梢血管デバイス使用の増加
  • 市場の課題
    • 厳しい規制と製品リコールの増加

ポーターの5つの力:末梢血管デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:末梢血管デバイス市場における外部からの影響の把握

外部マクロ環境要因は、末梢血管デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析末梢血管デバイス市場における競合情勢の把握

末梢血管デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス末梢血管デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、末梢血管デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨末梢血管デバイス市場における成功への道筋を描く

末梢血管デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 肥満、糖尿病、高血圧に関連する末梢血管疾患の増加
      • 低侵襲治療オプションの需要増加
      • 世界中で高齢化が進む
    • 抑制要因
      • デバイスの設置とメンテナンスにかかるコストが高い
    • 機会
      • 末梢血管デバイスにおける技術進歩の進展
      • 小児科患者における末梢血管デバイスの使用増加
    • 課題
      • 厳しい規制と製品リコールの増加
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 末梢血管デバイス市場:製品別

  • 血管形成術用バルーン
  • 血管形成ステント
  • バルーン膨張装置
  • カテーテル
  • EVARステントグラフト
  • ガイドワイヤー
  • 血行動態血流調節装置
  • 下大静脈フィルター
  • イントロデューサーシース
  • プラーク修正装置
  • 血管閉鎖デバイス

第7章 末梢血管デバイス市場:エンドユーザー別

  • 病院
  • 専門クリニック

第8章 南北アメリカの末梢血管デバイス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋の末梢血管デバイス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの末梢血管デバイス市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Amecath
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Esaote S.p.A.
  • Fresenius Medical Care AG & Co. KGaA
  • FUJIFILM Corporation
  • Kimal PLC
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • Medtronic PLC
  • Nipro Corporation
  • Siemens AG
図表

LIST OF FIGURES

  • FIGURE 1. PERIPHERAL VASCULAR DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PERIPHERAL VASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PERIPHERAL VASCULAR DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EVAR STENT GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCER SHEATHS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 43. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. INDIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 45. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. INDONESIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 47. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. JAPAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 49. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MALAYSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. PHILIPPINES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 53. SINGAPORE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. SINGAPORE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 55. SOUTH KOREA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. SOUTH KOREA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. TAIWAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. TAIWAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 59. THAILAND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. THAILAND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 61. VIETNAM PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. VIETNAM PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. DENMARK PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. DENMARK PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 68. EGYPT PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. EGYPT PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 70. FINLAND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. FINLAND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. FRANCE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. FRANCE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 74. GERMANY PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. GERMANY PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. ISRAEL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ISRAEL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 78. ITALY PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. ITALY PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 80. NETHERLANDS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. NETHERLANDS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. NIGERIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. NIGERIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 84. NORWAY PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. NORWAY PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 86. POLAND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. POLAND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. QATAR PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. QATAR PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 90. RUSSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. RUSSIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 92. SAUDI ARABIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SAUDI ARABIA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 96. SPAIN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SPAIN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 98. SWEDEN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SWEDEN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 100. SWITZERLAND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SWITZERLAND PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 102. TURKEY PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. TURKEY PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED ARAB EMIRATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED ARAB EMIRATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED KINGDOM PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED KINGDOM PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 108. PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 109. PERIPHERAL VASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-374DB5A063C3

The Peripheral Vascular Devices Market was valued at USD 16.24 billion in 2023, expected to reach USD 18.23 billion in 2024, and is projected to grow at a CAGR of 12.73%, to USD 37.58 billion by 2030.

Peripheral Vascular Devices (PVDs) encompass medical devices used to diagnose and treat blood vessel-related conditions outside the heart and brain, primarily in the peripheral circulatory system. These devices are essential in managing Peripheral Vascular Disease, which can lead to severe complications like blood clots or limb amputation. Applications include angioplasty, stenting, thrombectomy, and atherectomy, serving hospitals, specialty clinics, and ambulatory surgical centers. Factors propelling market growth include the rising prevalence of lifestyle-related diseases such as diabetes and obesity, an aging global population, and technological advancements in minimally invasive procedures. There's increasing demand for PVDs in emerging markets due to improved healthcare infrastructures and rising healthcare expenditures. Key opportunities lie in the development of drug-eluting devices and bioresorbable stents, which address limitations of current technologies, like restenosis and foreign body reactions. To seize these opportunities, companies should invest in innovative R&D and strategic partnerships. However, challenges like stringent regulatory approvals, high costs of advanced devices, and reimbursement issues can hinder market expansion. Competition from alternative therapies and the need for skilled healthcare professionals adds further complexity. Innovations should focus on enhancing device biocompatibility, reducing procedural risks, and improving patient outcomes through personalized medical devices. Companies should also explore hybrid technologies that integrate diagnostics with treatment. The nature of the PVD market is dynamic and competitive, driven by continuous advancements and evolving regulatory standards. Staying ahead necessitates keeping abreast of technological innovations, patient demographics, and healthcare policy changes. Emphasis on eco-friendly materials and cost-effective solutions could open new market segments. To drive business growth, engaging in proactive patient education campaigns and building robust distribution networks in emerging markets are vital strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 16.24 billion
Estimated Year [2024] USD 18.23 billion
Forecast Year [2030] USD 37.58 billion
CAGR (%) 12.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Peripheral Vascular Devices Market

The Peripheral Vascular Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • The increasing prevalence of peripheral vascular diseases associated with obesity, diabetes, and hypertension
    • Increasing demand for minimally invasive treatment options
    • Emerging worldwide geriatric population
  • Market Restraints
    • High cost associated with placement and maintenance of device
  • Market Opportunities
    • Growing technological advancement in the peripheral vascular devices
    • Rising use of peripheral vascular devices among pediatrics patients
  • Market Challenges
    • Stringent regulations and rising number of product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Peripheral Vascular Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Peripheral Vascular Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Peripheral Vascular Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Peripheral Vascular Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Peripheral Vascular Devices Market

A detailed market share analysis in the Peripheral Vascular Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Peripheral Vascular Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Peripheral Vascular Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Peripheral Vascular Devices Market

A strategic analysis of the Peripheral Vascular Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peripheral Vascular Devices Market, highlighting leading vendors and their innovative profiles. These include Amecath, AngioDynamics, Inc., Argon Medical Devices, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cook Group Incorporated, Esaote S.p.A., Fresenius Medical Care AG & Co. KGaA, FUJIFILM Corporation, Kimal PLC, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Nipro Corporation, and Siemens AG.

Market Segmentation & Coverage

This research report categorizes the Peripheral Vascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Angioplasty Balloons, Angioplasty Stents, Balloon Inflation Devices, Catheters, EVAR Stent Grafts, Guidewires, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, Introducer Sheaths, Plaque Modification Devices, and Vascular Closure Devices.
  • Based on End Users, market is studied across Hospitals and Speciality Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. The increasing prevalence of peripheral vascular diseases associated with obesity, diabetes, and hypertension
      • 5.1.1.2. Increasing demand for minimally invasive treatment options
      • 5.1.1.3. Emerging worldwide geriatric population
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with placement and maintenance of device
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing technological advancement in the peripheral vascular devices
      • 5.1.3.2. Rising use of peripheral vascular devices among pediatrics patients
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and rising number of product recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Peripheral Vascular Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Angioplasty Balloons
  • 6.3. Angioplasty Stents
  • 6.4. Balloon Inflation Devices
  • 6.5. Catheters
  • 6.6. EVAR Stent Grafts
  • 6.7. Guidewires
  • 6.8. Hemodynamic Flow Alteration Devices
  • 6.9. Inferior Vena Cava Filters
  • 6.10. Introducer Sheaths
  • 6.11. Plaque Modification Devices
  • 6.12. Vascular Closure Devices

7. Peripheral Vascular Devices Market, by End Users

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Speciality Clinics

8. Americas Peripheral Vascular Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Peripheral Vascular Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Peripheral Vascular Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amecath
  • 2. AngioDynamics, Inc.
  • 3. Argon Medical Devices, Inc.
  • 4. B. Braun SE
  • 5. Baxter International Inc.
  • 6. Becton, Dickinson and Company
  • 7. Cook Group Incorporated
  • 8. Esaote S.p.A.
  • 9. Fresenius Medical Care AG & Co. KGaA
  • 10. FUJIFILM Corporation
  • 11. Kimal PLC
  • 12. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 13. Medtronic PLC
  • 14. Nipro Corporation
  • 15. Siemens AG